LONDON - Drugmaker GlaxoSmithKline - hit by bribery claims in five countries - is to employ hundreds more doctors as members of staff as it seeks to build a new sales model designed to eliminate sharp marketing practices.
WASHINGTON - Complaints of injury linked to e-cigarettes, from burns and nicotine toxicity to respiratory and cardiovascular problems, have jumped over the past year as the devices become more popular, the most recent U.S. data show.
- Teva Pharmaceutical Industries Ltd said it settled a patent lawsuit with Pfizer Inc, allowing the Israeli drugmaker to launch a generic version of Pfizer's blockbuster painkiller Celebrex in December.
BEIJING/SHANGHAI - China has backtracked on its policy of capping retail prices on medicines and will allow pharmaceutical companies to set prices for some drugs, after criticism that controls had caused a drug drought that derailed treatment for millions of patients.
CONAKRY - The death toll from an Ebola outbreak in Guinea has risen to 122, the World Health Organisation said on Thursday, a sharp increase from a previous figure of 108.
PARIS - Jacques Servier, founder and president of France's second-largest drugmaker, has died before his trial over Mediator, a weight-loss pill at the center of the country's biggest public health scandal in years.
BRUSSELS - Belgian biotech group Galapagos NV on Thursday said it has successfully concluded the phase 2a study of a skin disease drug it is developing with Britain's GlaxoSmithKline PLC.
SACRAMENTO, California - California on Wednesday made it harder for health insurers to deny or delay coverage of key interventions for children with autism, the latest in an ongoing series of actions by U.S. states to help families obtain the expensive therapies.
- Britain's Foods Standards Agency (FSA) said it will begin a new round of tests on lamb takeaway meals from restaurants across the UK after the consumer watchdog found evidence of cheaper substitutes such as beef and chicken.
LONDON - Scientists and drugmakers are pioneering a new kind of clinical trial that changes the way cancer drugs are studied, potentially cutting both the time and cost of bringing them to market.
A series that looks at all facets of cancer, written by Debra Sherman, a stage 4 lung cancer patient. Debra covered the health beat for Reuters for more than a decade and is using her knowledge about health, her contacts in the industry and her personal experiences to report this series. Full Article